The role of hypoxia related angiogenesis in uterine smooth muscle tumors

References

• Anderson P, Kedersha N (2009)RNA granules: post- transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 10: 430–436.
   PubMed Web of Science ®Google Scholar
• Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC (2006)Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res. 66: 5641–5647.
   PubMed Web of Science ®Google Scholar
• Bhadada SV, Goyal BR, Patel MM (2011)Angiogenic targets for potential disorders. Fund. Clin. Pharmacol. 25: 29–47.
   PubMed Web of Science ®Google Scholar
• Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K (2006)Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study. Gynecol. Oncol. 103: 186–189.
   PubMed Web of Science ®Google Scholar
• Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E (2001)Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93: 309–314.
   PubMed Web of Science ®Google Scholar
• Brown JM, Wilson WR (2004)Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4: 437–447.
   PubMed Web of Science ®Google Scholar
• Campbell SC, Volpert OV, Ivanovich M, Bouck NP (1998)Molecular mediators of angiogenesis in bladder cancer. Cancer Res. 58: 1298–1304.
   PubMed Web of Science ®Google Scholar
• Cardenas-Navia LI, Mace D, Richardson RA, Wilson DF, Shan S, Dewhirst MW (2008)The pervasive presence of fluctuating oxygenation in tumors. Cancer Res. 68: 5812–5819.
   PubMed Web of Science ®Google Scholar
• Clemens MJ (2004)Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23: 3180–3188.
   PubMedGoogle Scholar
• Connolly E, Braunstein S, Formenti S, Schneider RJ (2006)Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol. Cell. Biol. 26: 3955–3965.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW (2007)Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res. 67: 854–855.
   PubMed Web of Science ®Google Scholar
• Di Lieto A, De Falco M, Pollio F, Mansueto G, Salvatore G, Somma P, Ciociola F, De Rosa G, Staibano S (2005)Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J. Soc. Gynecol. Invest. 12: 123–128.
   PubMedGoogle Scholar
• Folkman J (1986)How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res. 46: 467–473.
   PubMed Web of Science ®Google Scholar
• Folkman J (2006)Angiogenesis. Ann. Rev. Med. 57: 1–18.
   Google Scholar
• Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ (2003)Inhibition of constitutive NF-ĸB activity by IĸBαM suppresses tumorigenesis. Oncogene 22: 1365–1370.
   PubMed Web of Science ®Google Scholar
• Gardner LB, Corn PG (2008)Hypoxic regulation of mRNA expression. Cell Cycle 7: 1916–1924.
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL (2001)Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer 85: 881–890.
   PubMed Web of Science ®Google Scholar
• Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM, Anderson P (2004)Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 15: 5383–5398.
   PubMed Web of Science ®Google Scholar
• Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP (1990)A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87: 6624–6628.
   PubMed Web of Science ®Google Scholar
• Goonewardene TI, Sowter HM, Harris AL (2002)Hypoxia-induced pathways in breast cancer. Microsc. Res. Tech. 59: 41–48.
   PubMedGoogle Scholar
• Gottschald OR, Malec V, Krasteva G, Hasan D, Kamlah F, Herold S, Rose F, Seeger W, Hanze J (2010)TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1α pathway. J. Mol. Cell Biol. 2: 345–356.
   Google Scholar
• Han Y, Zhou Y, Zheng S (2002)Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus. Zhong. Fu Chan Ke Za Zhi. 37: 539–541.
   PubMedGoogle Scholar
• Hong T, Shimada Y, Uchida S, Itami A, Li Z, Ding Y, Kaganoi J, Komoto I, Sakurai T, Imamura M (2001)Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int. J. Mol. Med. 8: 141–148.
   PubMed Web of Science ®Google Scholar
• Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ (2000)Blockade of nuclear factor-ĸB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 60: 5334–5339.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004)Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350: 2335–2342.
   PubMed Web of Science ®Google Scholar
• Jin K, Li W, Nagayama T, He X, Sinor AD, Chang J, Mao X, Graham SH, Simon RP, Greenberg DA (2000)Expression of the RNA-binding protein TIAR is increased in neurons after ischemic cerebral injury. J. Neurosci. Res. 59: 767–774.
   PubMed Web of Science ®Google Scholar
• Jud MC, Czerwinski MJ, Wood MP, Young RA, Gallo CM, Bickel JS, Petty EL, Mason JM, Little BA, Padilla PA, Schisa JA (2008)Large P body-like RNPs form in C. elegans oocytes in response to arrested ovulation, heat shock, osmotic stress, and anoxia and are regulated by the major sperm protein pathway. Dev. Biol. 318: 38–51.
   Google Scholar
• Kazerounian S, Yee KO, Lawler J (2008)Thrombospondins in cancer. Cell Mol. Life Sci. 65: 700–712.
   PubMed Web of Science ®Google Scholar
• Kedersha N, Anderson P (2007)Mammalian stress granules and processing bodies. Methods Enzymol. 431: 61–81.
   PubMed Web of Science ®Google Scholar
• Kedersha N, Tisdale S, Hickman T, Anderson P (2008)Real-time and quantitative imaging of mammalian stress granules and processing bodies. Methods Enzymol. 448: 521–552.
   PubMed Web of Science ®Google Scholar
• Kedersha N, Ivanov P, Anderson P (2013)Stress granules and cell signaling: more than just a passing phase. Trends Biochem. Sci. 38: 494–506.
   PubMed Web of Science ®Google Scholar
• Kiriakidis S, Andreakos E, Monaco C, Foxwell B, Feldmann M, Paleolog E (2003)VEGF expression in human macrophages is NF-ĸB-dependent: studies using adenoviruses expressing the endogenous NF-ĸB inhibitor IĸBα and a kinase-defective form of the IĸB kinase 2. J. Cell Sci. 116: 665–674.
   PubMed Web of Science ®Google Scholar
• Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG (2006)Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 25: 1114–1125.
   PubMed Web of Science ®Google Scholar
• Koumenis C, Wouters BG (2006)‘’Translating’’ tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 4: 423–436.
   PubMed Web of Science ®Google Scholar
• Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG (2002)Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell Biol. 22: 7405–7416.
   PubMed Web of Science ®Google Scholar
• Liekens S, De Clercq E, Neyts J (2001)Angiogenesis: regulators and clinical applications. Biochem. Pharmacol. 61: 253–270.
   PubMed Web of Science ®Google Scholar
• Lou JJ, Chua YL, Chew EH, Gao J, Bushell M, Hagen T (2010)Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PLoS One 5: e10522.
   PubMedGoogle Scholar
• Lu X, Kang Y (2010)Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 16: 5928–5935.
   PubMed Web of Science ®Google Scholar
• Magagnin MG, van den Beucken T, Sergeant K, Lambin P, Koritzinsky M, Devreese B, Wouters BG (2008)The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency. Proteomics 8: 1019–1028.
   PubMed Web of Science ®Google Scholar
• Masuda K, Abdelmohsen K, Gorospe M (2009)RNA-binding proteins implicated in the hypoxic response. J. Cell. Mol. Med. 3: 2759–2769.
   Google Scholar
• Mazan-Mamczarz K, Lal A, Martindale JL, Kawai T, Gorospe M (2006). Translational repression by RNA-binding protein TIAR. Mol. Cell Biol. 26: 2716–2727.
   PubMed Web of Science ®Google Scholar
• Messmer-Blust A, An X, Li J (2009)Hypoxia-regulated angiogenic inhibitors. Trends Cardiovasc. Med. 19: 252–256.
   PubMed Web of Science ®Google Scholar
• Mirochnik Y, Kwiatek A, Volpert OV (2008)Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. Curr. Drug Targets 9: 851–862.
   PubMed Web of Science ®Google Scholar
• Mizukami Y, Li J, Zhang X, Zimmer MA, Iliopoulos O, Chung DC (2004)Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res. 64: 1765–1772.
   PubMed Web of Science ®Google Scholar
• Mizukami Y, Kohgo Y, Chung DC (2007)Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin. Cancer Res. 13: 5670–5674.
   PubMed Web of Science ®Google Scholar
• Moeller BJ, Dewhirst MW (2004)Raising the bar: how HIF-1 helps determine tumor radiosensitivity. Cell Cycle 3: 1107–1110.
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999)Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 3: 9–22.
   Google Scholar
• Papadakis AI, Paraskeva E, Peidis P, Muaddi H, Li S, Raptis L, Pantopoulos K, Simos G, Koromilas AE (2010)eIF2{alpha} Kinase PKR modulates the hypoxic response by Stat3-dependent transcriptional suppression of HIF- 1{alpha}. Cancer Res. 70: 7820–7829.
   PubMed Web of Science ®Google Scholar
• Robboy SJ, Bentley RC, Butnor K, Anderson MC (2000)Pathology and pathophysiology of uterine smooth muscle tumors. Environ. Health Perspec. 108: 779–784.
   PubMed Web of Science ®Google Scholar
• Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS (2011)Anti-angiogenic peptides for cancer therapeutics. Curr. Pharm. Biotechnol. 12: 1101–1116.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Lo J, Johnson RS (1998)HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17: 3005–3015.
   PubMed Web of Science ®Google Scholar
• Sanci M, Dikis C, Inan S, Turkoz E, Dicle N, Ispahi C (2011)Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma. Acta Histochem. 113: 317–325.
   PubMed Web of Science ®Google Scholar
• Semenza GL (2000)HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88: 1474–1480.
   PubMed Web of Science ®Google Scholar
• Semenza GL (2002)HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8: 62–67.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A (1996)Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 71: 32529–32537.
   Google Scholar
• Shi YH, Fang WG (2004)Hypoxia-inducible factor-1 in tumour angiogenesis. World J. Gastroenterol. 10: 1082–1087.
   PubMed Web of Science ®Google Scholar
• Solomon LA, Schimp VL, Ali-Fehmi R, Diamond MP, Munkarah AR (2005)Clinical update of smooth muscle tumors of the uterus. J. Min. Invas. Gynecol. 12: 401–408.
   PubMed Web of Science ®Google Scholar
• Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000)The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157: 411–421.
   PubMed Web of Science ®Google Scholar
• Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LYC (2005)Expression and functional analysis of pituitary tumor transforming growth factor-1 in uterine leiomyomas. J. Clin. Endocrinol. Metab. 90: 3715–3723.
   PubMed Web of Science ®Google Scholar
• van den Beucken T, Koritzinsky M, Wouters BG (2006)Translational control of gene expression during hypoxia. Cancer Biol. Ther. 5: 749–755.
   PubMed Web of Science ®Google Scholar
• Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M, Nagasue N (2004)Prognostic impact of hypoxia-inducible factors 1-alpha and 2-alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin. Cancer Res. 10: 8554–8560.
   PubMed Web of Science ®Google Scholar
• Zabrenetzky V, Harris CC, Steeg PS, Roberts DD (1994)Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59: 191–195.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cao J, Weng Q, Wu R, Yan Y, Jing H, Zhu H, He Q, Yang B (2010)Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One 5: e13910.
   PubMedGoogle Scholar
• Zhang YW, Su Y, Volpert OV, Vande Woude GF (2003)Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100: 12718–12723.
   PubMed Web of Science ®Google Scholar
• Zhu K, Chan W, Heymach J, Wilkinson M, McConkey DJ (2009)Control of HIF-1alpha expression by eIF2 alpha phosphorylation-mediated translational repression. Cancer Res. 69: 1836–1843.
   PubMed Web of Science ®Google Scholar